The Patent Finder

Terms ending in 2029

Abraxis Bioscience, LLC

Every in-force patent on Abraxis Bioscience, LLC's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 7,799,954Dicarbonyl Derivatives and Methods of Use
In force
 · High confidence
Nantbioscience, Inc.In forceHigh confidence
US 8,003,402Method for Measuring the Concentration of a Glycosaminoglycan Anticoagulant
In force
 · High confidence
Active Biomaterials LLCIn forceHigh confidence
US 8,034,765Compositions and Methods for Preparation of Poorly Water Soluble Drugs with Increased Stability
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 8,821,836Sparc Binding Peptides and Uses Thereof
In force
 · Low confidence
Abraxis BioScience, LLCIn forceLow confidence
US 9,295,733Sparc Binding Scfvs
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 10,053,504Sparc Binding Scfvs
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Abraxis Bioscience, LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited